Novo Nordisk
NVO
#15
Rank
NZ$910.05 B
Marketcap
$206.10
Share price
-5.46%
Change (1 day)
29.07%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$13.27 B

According to Novo Nordisk's latest financial reports the company's total debt is NZ$13.27 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Novo Nordisk - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$6.32 B8.14%
2022-12-31NZ$5.84 B-1.27%
2021-12-31NZ$5.92 B148.86%
2020-12-31NZ$2.38 B138.87%
2019-12-31NZ$0.99 B747.46%
2018-12-31NZ$0.11 B-69.42%
2017-12-31NZ$0.38 B721.49%
2016-12-31NZ$46.8 M-79.65%
2015-12-31NZ$0.23 B53.44%
2014-12-31NZ$0.14 B209.29%
2013-12-31NZ$48.46 M-55.18%
2012-12-31NZ$0.10 B-43.2%
2011-12-31NZ$0.19 B-63.14%
2010-12-31NZ$0.51 B39.29%
2009-12-31NZ$0.37 B-50.93%
2008-12-31NZ$0.75 B118.51%
2007-12-31NZ$0.34 B-9.27%
2006-12-31NZ$0.38 B-38.88%
2005-12-31NZ$0.62 B43.21%
2004-12-31NZ$0.43 B-3.4%
2003-12-31NZ$0.45 B14.51%
2002-12-31NZ$0.39 B-34.77%
2001-12-31NZ$0.60 B2.05%
2000-12-31NZ$0.59 B3.87%
1999-12-31NZ$0.56 B-26.74%
1998-12-31NZ$0.77 B-2.14%
1997-12-31NZ$0.79 B64.43%
1996-12-31NZ$0.48 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
NZ$111.00 B 736.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$46.70 B 251.75%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$87.29 B 557.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$41.15 B 209.97%๐Ÿ‡ซ๐Ÿ‡ท France